255 related articles for article (PubMed ID: 20821239)
1. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
[TBL] [Abstract][Full Text] [Related]
2. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
Xiang X; Zhao WB; Wang X
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
[TBL] [Abstract][Full Text] [Related]
3. ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer.
Kang YH; Ji NY; Han SR; Lee CI; Kim JW; Yeom YI; Kim YH; Chun HK; Kim JW; Chung JW; Ahn DK; Lee HG; Song EY
Cell Signal; 2012 Oct; 24(10):1940-9. PubMed ID: 22735811
[TBL] [Abstract][Full Text] [Related]
4. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
6. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
8. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
9. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
[TBL] [Abstract][Full Text] [Related]
12. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
13. Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features.
Kim JH; Park MY; Kim CN; Kim KH; Kang HB; Kim KD; Kim JW
Oncol Rep; 2012 Nov; 28(5):1701-8. PubMed ID: 22948784
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
15. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
Hayashi Y; Osanai M; Lee GH
Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma.
Cheng ZX; Huang XH; Wang Q; Chen JS; Zhang LJ; Chen XL
J Surg Oncol; 2012 Jan; 105(1):71-80. PubMed ID: 21815147
[TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
18. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
